Medistim ASA
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in… Read more
Medistim ASA (MEDI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.098x
Based on the latest financial reports, Medistim ASA (MEDI) has a cash flow conversion efficiency ratio of 0.098x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr37.65 Million) by net assets (Nkr383.81 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Medistim ASA - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how Medistim ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Medistim ASA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medistim ASA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Inzone Group Co Ltd
SHG:600858
|
0.186x |
|
ToolGen Inc.
KQ:199800
|
-0.094x |
|
Akcansa Cimento Sanayi ve Ticaret AS
IS:AKCNS
|
0.041x |
|
BCPG Public Company Limited
BK:BCPG
|
0.032x |
|
WIRTUALNA POL.BC ZY -05
F:9DE
|
N/A |
|
Hefei Gocom Information Technology Co Ltd
SHG:688367
|
0.036x |
|
Alico Inc
NASDAQ:ALCO
|
-0.052x |
|
Lanzhou Foci Pharmaceutical Co Ltd
SHE:002644
|
0.041x |
Annual Cash Flow Conversion Efficiency for Medistim ASA (2004–2024)
The table below shows the annual cash flow conversion efficiency of Medistim ASA from 2004 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Nkr436.61 Million | Nkr143.10 Million | 0.328x | +15.23% |
| 2023-12-31 | Nkr397.94 Million | Nkr113.19 Million | 0.284x | -8.70% |
| 2022-12-31 | Nkr367.69 Million | Nkr114.56 Million | 0.312x | -25.59% |
| 2021-12-31 | Nkr306.05 Million | Nkr128.14 Million | 0.419x | +45.06% |
| 2020-12-31 | Nkr256.85 Million | Nkr74.13 Million | 0.289x | -14.95% |
| 2019-12-31 | Nkr236.86 Million | Nkr80.38 Million | 0.339x | +25.73% |
| 2018-12-31 | Nkr206.71 Million | Nkr55.79 Million | 0.270x | -17.83% |
| 2017-12-31 | Nkr182.98 Million | Nkr60.10 Million | 0.328x | +79.69% |
| 2016-12-31 | Nkr166.70 Million | Nkr30.47 Million | 0.183x | -36.08% |
| 2015-12-31 | Nkr156.16 Million | Nkr44.66 Million | 0.286x | -18.72% |
| 2014-12-31 | Nkr139.10 Million | Nkr48.94 Million | 0.352x | +64.32% |
| 2013-12-31 | Nkr121.64 Million | Nkr26.04 Million | 0.214x | -6.06% |
| 2012-12-31 | Nkr115.17 Million | Nkr26.25 Million | 0.228x | -1.22% |
| 2011-12-31 | Nkr106.89 Million | Nkr24.66 Million | 0.231x | -33.24% |
| 2010-12-31 | Nkr107.83 Million | Nkr37.27 Million | 0.346x | +12.06% |
| 2009-12-31 | Nkr106.29 Million | Nkr32.78 Million | 0.308x | +10.02% |
| 2008-12-31 | Nkr95.46 Million | Nkr26.76 Million | 0.280x | +26.46% |
| 2007-12-31 | Nkr93.83 Million | Nkr20.80 Million | 0.222x | -5.17% |
| 2006-12-31 | Nkr74.06 Million | Nkr17.31 Million | 0.234x | +5.83% |
| 2005-12-31 | Nkr67.41 Million | Nkr14.89 Million | 0.221x | +152.67% |
| 2004-12-31 | Nkr61.71 Million | Nkr5.39 Million | 0.087x | -- |